PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 55 filers reported holding PASSAGE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,648,629 | -29.8% | 2,497,922 | 0.0% | 2.12% | +5.0% |
Q2 2023 | $2,348,047 | -2.1% | 2,497,922 | 0.0% | 2.02% | +1.8% |
Q1 2023 | $2,398,005 | -30.4% | 2,497,922 | 0.0% | 1.98% | -20.6% |
Q4 2022 | $3,447,132 | +10.4% | 2,497,922 | 0.0% | 2.50% | +34.8% |
Q3 2022 | $3,122,000 | -47.0% | 2,497,922 | 0.0% | 1.85% | -51.5% |
Q2 2022 | $5,895,000 | -23.9% | 2,497,922 | 0.0% | 3.82% | +0.1% |
Q1 2022 | $7,744,000 | -51.2% | 2,497,922 | 0.0% | 3.82% | -33.6% |
Q4 2021 | $15,862,000 | -36.2% | 2,497,922 | 0.0% | 5.75% | -19.9% |
Q3 2021 | $24,879,000 | +1591.3% | 2,497,922 | 0.0% | 7.18% | +1798.4% |
Q2 2021 | $1,471,000 | -96.6% | 2,497,922 | 0.0% | 0.38% | -96.3% |
Q1 2021 | $43,664,000 | -31.6% | 2,497,922 | 0.0% | 10.16% | -31.1% |
Q4 2020 | $63,872,000 | +95.0% | 2,497,922 | 0.0% | 14.76% | +11.8% |
Q3 2020 | $32,748,000 | -52.0% | 2,497,922 | 0.0% | 13.20% | -32.6% |
Q2 2020 | $68,268,000 | +73.5% | 2,497,922 | 0.0% | 19.59% | +66.4% |
Q1 2020 | $39,342,000 | – | 2,497,922 | – | 11.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $6,200,000 | 10.57% |
Lynx1 Capital Management LP | 2,752,422 | $3,441,000 | 3.10% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $1,545,000 | 2.89% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,122,000 | 1.85% |
Frazier Life Sciences Management, L.P. | 3,756,915 | $4,696,000 | 0.36% |
Orbimed Advisors | 8,931,999 | $11,165,000 | 0.21% |
Newtyn Management, LLC | 300,000 | $375,000 | 0.08% |
Deep Track Capital, LP | 1,439,062 | $1,799,000 | 0.08% |
Rubric Capital Management LP | 822,105 | $1,028,000 | 0.05% |
Oasis Management Co Ltd. | 240,000 | $300,000 | 0.05% |